Cargando…
Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication
Autores principales: | D’Ambrosio, Roberta, Ioannou, George N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435272/ https://www.ncbi.nlm.nih.gov/pubmed/34510832 http://dx.doi.org/10.1002/hep4.1733 |
Ejemplares similares
-
Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy
por: D’Ambrosio, Roberta, et al.
Publicado: (2015) -
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus
por: Tamaki, Nobuharu, et al.
Publicado: (2021) -
Clinical and Molecular Basis of Hepatocellular Carcinoma after Hepatitis C Virus Eradication
por: Oe, Natsumi, et al.
Publicado: (2022) -
The Challenging Road to Hepatitis C Virus Eradication
por: Martínez, Isidoro, et al.
Publicado: (2021) -
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication
por: Lu, Ming-Ying, et al.
Publicado: (2022)